COVID19's Impact on Refugee/Migrant Equity-Deserving Groups in Latin America

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:239 publications

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2022
  • Known Financial Commitments (USD)

    $384,965.35
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    Queen's University
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Internally Displaced and MigrantsSexual and gender minorities

  • Occupations of Interest

    Unspecified

Abstract

Venezuela has been experiencing a severe socioeconomic and political crisis for several years, now compounded by COVID19. With 7.5 million people in need of humanitarian assistance in Venezuela and another 5.6 million Venezuelans in need in other countries, it is now the world's second-largest external displacement crisis after Syria. COVID19 has exacerbated long-standing socioeconomic inequalities between migrants and local communities. This has created an urgent need for research on how the COVID19 pandemic is impacting refugees and migrants in Latin America as well as differential and disproportionate effects on known equity-deserving groups. We will conduct mixed methods research using an innovative 'SenseMaking' (SM) approach to understand the broader impacts of COVID19 in Latin America with a particular focus on different groups of refugees and migrants, including women/girls, LGBTIQ+ individuals, and persons with disabilities. SM is based on the recognition that storytelling is a natural way to convey complex information and is used by individuals to make sense of their experiences. Using SM, participants audio-record a story in response to an open-ended prompt, thus generating the qualitative data. After the recording, participants then interpret their own experiences by plotting their perspectives. SM quantifies each of the plotted points, providing statistical data backed up by the accompanying explanatory narratives. Multiple-choice questions collect demographic information and help to contextualize the shared story. By collecting many self-interpreted stories, SM leverages the "wisdom of the crowds," and collectively, the participants' interpretation responses create a nuanced picture in the same way pixels come together to produce a clear image. Objectives: We will use SM to holistically examine the social, economic, security, health, and cultural impacts of COVID19 among refugee/migrant equity-deserving groups in Latin America.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.

Identification and Characterization of a Rare Exon 22 Duplication in <i>CFTR</i> in Two Families.

Structural Rearrangement in Cyclic Cu(II) Pyridyltriazole Complexes: Oxidation of Dabco to Oxalate and CO<sub>2</sub> Conversion to Carbonate.

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.